DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Arzeda is leveraging artificial intelligence to design proteins for artificial sweeteners and other applications. The company has secured $38 million in an oversubscribed funding round to advance its protein design commercialization efforts, as reported by TechCrunch. This development is part of a broader trend where AI is increasingly applied to protein design, aimed at creating new proteins with specific, targeted characteristics. Meanwhile, Nomic® Bio has closed a $42 million Series B round to expand access to protein profiling, with over 400,000 samples already profiled using its nELISA technology.
Interpretable ML in computational biology could revolutionize research by bridging complex data with clear insights! 🌟 Are we on the brink of more breakthroughs with interpretable models that enhance discovery and understanding? #ArtificialIntelligence #Bioinformatics
AI revolutionizes proteomics! By interpreting complex protein data and integrating evolving scientific knowledge, AI offers deeper insights and faster research advancements 🧬 How do you think AI will further transform biotechnological fields? #AI #Proteomics
AlphaProteo: Google DeepMind’s Breakthrough in Protein Design #automation #AI #RoboticsAINews https://t.co/ErrIpMDaQG https://t.co/RLTajkXu1q
